▶ 調査レポート

世界のC-Cケモカイン受容体タイプ4市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global C-C Chemokine Receptor Type 4 Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のC-Cケモカイン受容体タイプ4市場規模・現状・予測(2021年-2027年) / Global C-C Chemokine Receptor Type 4 Market Size, Status and Forecast 2021-2027 / QFJ1-5648資料のイメージです。• レポートコード:QFJ1-5648
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、C-Cケモカイン受容体タイプ4の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(CCX-6239、E-0001163、GBV-3019、K-777、その他)、用途別市場規模(免疫学、中枢神経系、菌状息肉腫、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・C-Cケモカイン受容体タイプ4の市場動向
・企業の競争状況、市場シェア
・C-Cケモカイン受容体タイプ4の種類別市場規模と予測2016-2027(CCX-6239、E-0001163、GBV-3019、K-777、その他)
・C-Cケモカイン受容体タイプ4の用途別市場規模と予測2016-2027(免疫学、中枢神経系、菌状息肉腫、その他)
・C-Cケモカイン受容体タイプ4の北米市場規模2016-2027(アメリカ、カナダ)
・C-Cケモカイン受容体タイプ4の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・C-Cケモカイン受容体タイプ4のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・C-Cケモカイン受容体タイプ4の中南米市場規模2016-2027(メキシコ、ブラジル)
・C-Cケモカイン受容体タイプ4の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Affitech A/S、AstraZeneca Plc、ChemoCentryx Inc、Corion Biotech Srl、FLX Bio Inc、Globavir Biosciences Inc、Kyowa Hakko Kirin Co Ltd、Ono Pharmaceutical Co Ltd)
・結論

Market Analysis and Insights: Global C-C Chemokine Receptor Type 4 Market
The global C-C Chemokine Receptor Type 4 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global C-C Chemokine Receptor Type 4 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global C-C Chemokine Receptor Type 4 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global C-C Chemokine Receptor Type 4 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global C-C Chemokine Receptor Type 4 market.

Global C-C Chemokine Receptor Type 4 Scope and Market Size
C-C Chemokine Receptor Type 4 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global C-C Chemokine Receptor Type 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CCX-6239
E-0001163
GBV-3019
K-777
Others

Segment by Application
Immunology
Central Nervous System
Mycosis Fungoides
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Affitech A/S
AstraZeneca Plc
ChemoCentryx Inc
Corion Biotech Srl
FLX Bio Inc
Globavir Biosciences Inc
Kyowa Hakko Kirin Co Ltd
Ono Pharmaceutical Co Ltd

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CCX-6239
1.2.3 E-0001163
1.2.4 GBV-3019
1.2.5 K-777
1.2.6 Others
1.3 Market by Application
1.3.1 Global C-C Chemokine Receptor Type 4 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immunology
1.3.3 Central Nervous System
1.3.4 Mycosis Fungoides
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global C-C Chemokine Receptor Type 4 Market Perspective (2016-2027)
2.2 C-C Chemokine Receptor Type 4 Growth Trends by Regions
2.2.1 C-C Chemokine Receptor Type 4 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 C-C Chemokine Receptor Type 4 Historic Market Share by Regions (2016-2021)
2.2.3 C-C Chemokine Receptor Type 4 Forecasted Market Size by Regions (2022-2027)
2.3 C-C Chemokine Receptor Type 4 Industry Dynamic
2.3.1 C-C Chemokine Receptor Type 4 Market Trends
2.3.2 C-C Chemokine Receptor Type 4 Market Drivers
2.3.3 C-C Chemokine Receptor Type 4 Market Challenges
2.3.4 C-C Chemokine Receptor Type 4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top C-C Chemokine Receptor Type 4 Players by Revenue
3.1.1 Global Top C-C Chemokine Receptor Type 4 Players by Revenue (2016-2021)
3.1.2 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Players (2016-2021)
3.2 Global C-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by C-C Chemokine Receptor Type 4 Revenue
3.4 Global C-C Chemokine Receptor Type 4 Market Concentration Ratio
3.4.1 Global C-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-C Chemokine Receptor Type 4 Revenue in 2020
3.5 C-C Chemokine Receptor Type 4 Key Players Head office and Area Served
3.6 Key Players C-C Chemokine Receptor Type 4 Product Solution and Service
3.7 Date of Enter into C-C Chemokine Receptor Type 4 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 C-C Chemokine Receptor Type 4 Breakdown Data by Type
4.1 Global C-C Chemokine Receptor Type 4 Historic Market Size by Type (2016-2021)
4.2 Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2022-2027)

5 C-C Chemokine Receptor Type 4 Breakdown Data by Application
5.1 Global C-C Chemokine Receptor Type 4 Historic Market Size by Application (2016-2021)
5.2 Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America C-C Chemokine Receptor Type 4 Market Size (2016-2027)
6.2 North America C-C Chemokine Receptor Type 4 Market Size by Type
6.2.1 North America C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
6.2.2 North America C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
6.2.3 North America C-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
6.3 North America C-C Chemokine Receptor Type 4 Market Size by Application
6.3.1 North America C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
6.3.2 North America C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
6.3.3 North America C-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
6.4 North America C-C Chemokine Receptor Type 4 Market Size by Country
6.4.1 North America C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
6.4.2 North America C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe C-C Chemokine Receptor Type 4 Market Size (2016-2027)
7.2 Europe C-C Chemokine Receptor Type 4 Market Size by Type
7.2.1 Europe C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
7.2.2 Europe C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
7.2.3 Europe C-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
7.3 Europe C-C Chemokine Receptor Type 4 Market Size by Application
7.3.1 Europe C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
7.3.2 Europe C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
7.3.3 Europe C-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
7.4 Europe C-C Chemokine Receptor Type 4 Market Size by Country
7.4.1 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
7.4.2 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size (2016-2027)
8.2 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Type
8.2.1 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
8.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Application
8.3.1 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
8.4 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region
8.4.1 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America C-C Chemokine Receptor Type 4 Market Size (2016-2027)
9.2 Latin America C-C Chemokine Receptor Type 4 Market Size by Type
9.2.1 Latin America C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
9.2.2 Latin America C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
9.2.3 Latin America C-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
9.3 Latin America C-C Chemokine Receptor Type 4 Market Size by Application
9.3.1 Latin America C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
9.3.2 Latin America C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
9.3.3 Latin America C-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
9.4 Latin America C-C Chemokine Receptor Type 4 Market Size by Country
9.4.1 Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
9.4.2 Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size (2016-2027)
10.2 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type
10.2.1 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2016-2027)
10.3 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application
10.3.1 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2016-2027)
10.4 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country
10.4.1 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Affitech A/S
11.1.1 Affitech A/S Company Details
11.1.2 Affitech A/S Business Overview
11.1.3 Affitech A/S C-C Chemokine Receptor Type 4 Introduction
11.1.4 Affitech A/S Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.1.5 Affitech A/S Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Introduction
11.2.4 AstraZeneca Plc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 ChemoCentryx Inc
11.3.1 ChemoCentryx Inc Company Details
11.3.2 ChemoCentryx Inc Business Overview
11.3.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Introduction
11.3.4 ChemoCentryx Inc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.3.5 ChemoCentryx Inc Recent Development
11.4 Corion Biotech Srl
11.4.1 Corion Biotech Srl Company Details
11.4.2 Corion Biotech Srl Business Overview
11.4.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Introduction
11.4.4 Corion Biotech Srl Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.4.5 Corion Biotech Srl Recent Development
11.5 FLX Bio Inc
11.5.1 FLX Bio Inc Company Details
11.5.2 FLX Bio Inc Business Overview
11.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Introduction
11.5.4 FLX Bio Inc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.5.5 FLX Bio Inc Recent Development
11.6 Globavir Biosciences Inc
11.6.1 Globavir Biosciences Inc Company Details
11.6.2 Globavir Biosciences Inc Business Overview
11.6.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Introduction
11.6.4 Globavir Biosciences Inc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.6.5 Globavir Biosciences Inc Recent Development
11.7 Kyowa Hakko Kirin Co Ltd
11.7.1 Kyowa Hakko Kirin Co Ltd Company Details
11.7.2 Kyowa Hakko Kirin Co Ltd Business Overview
11.7.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Introduction
11.7.4 Kyowa Hakko Kirin Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.7.5 Kyowa Hakko Kirin Co Ltd Recent Development
11.8 Ono Pharmaceutical Co Ltd
11.8.1 Ono Pharmaceutical Co Ltd Company Details
11.8.2 Ono Pharmaceutical Co Ltd Business Overview
11.8.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Introduction
11.8.4 Ono Pharmaceutical Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021)
11.8.5 Ono Pharmaceutical Co Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CCX-6239
Table 3. Key Players of E-0001163
Table 4. Key Players of GBV-3019
Table 5. Key Players of K-777
Table 6. Key Players of Others
Table 7. Global C-C Chemokine Receptor Type 4 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global C-C Chemokine Receptor Type 4 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global C-C Chemokine Receptor Type 4 Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global C-C Chemokine Receptor Type 4 Market Share by Regions (2016-2021)
Table 11. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global C-C Chemokine Receptor Type 4 Market Share by Regions (2022-2027)
Table 13. C-C Chemokine Receptor Type 4 Market Trends
Table 14. C-C Chemokine Receptor Type 4 Market Drivers
Table 15. C-C Chemokine Receptor Type 4 Market Challenges
Table 16. C-C Chemokine Receptor Type 4 Market Restraints
Table 17. Global C-C Chemokine Receptor Type 4 Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global C-C Chemokine Receptor Type 4 Market Share by Players (2016-2021)
Table 19. Global Top C-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-C Chemokine Receptor Type 4 as of 2020)
Table 20. Ranking of Global Top C-C Chemokine Receptor Type 4 Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by C-C Chemokine Receptor Type 4 Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players C-C Chemokine Receptor Type 4 Product Solution and Service
Table 24. Date of Enter into C-C Chemokine Receptor Type 4 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 27. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2016-2021)
Table 28. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global C-C Chemokine Receptor Type 4 Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2016-2021)
Table 32. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 35. North America C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 37. North America C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2022-2027) & (US$ Million)
Table 64. Affitech A/S Company Details
Table 65. Affitech A/S Business Overview
Table 66. Affitech A/S C-C Chemokine Receptor Type 4 Product
Table 67. Affitech A/S Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 68. Affitech A/S Recent Development
Table 69. AstraZeneca Plc Company Details
Table 70. AstraZeneca Plc Business Overview
Table 71. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product
Table 72. AstraZeneca Plc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Plc Recent Development
Table 74. ChemoCentryx Inc Company Details
Table 75. ChemoCentryx Inc Business Overview
Table 76. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product
Table 77. ChemoCentryx Inc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 78. ChemoCentryx Inc Recent Development
Table 79. Corion Biotech Srl Company Details
Table 80. Corion Biotech Srl Business Overview
Table 81. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product
Table 82. Corion Biotech Srl Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 83. Corion Biotech Srl Recent Development
Table 84. FLX Bio Inc Company Details
Table 85. FLX Bio Inc Business Overview
Table 86. FLX Bio Inc C-C Chemokine Receptor Type 4 Product
Table 87. FLX Bio Inc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 88. FLX Bio Inc Recent Development
Table 89. Globavir Biosciences Inc Company Details
Table 90. Globavir Biosciences Inc Business Overview
Table 91. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product
Table 92. Globavir Biosciences Inc Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 93. Globavir Biosciences Inc Recent Development
Table 94. Kyowa Hakko Kirin Co Ltd Company Details
Table 95. Kyowa Hakko Kirin Co Ltd Business Overview
Table 96. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product
Table 97. Kyowa Hakko Kirin Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 98. Kyowa Hakko Kirin Co Ltd Recent Development
Table 99. Ono Pharmaceutical Co Ltd Company Details
Table 100. Ono Pharmaceutical Co Ltd Business Overview
Table 101. Ono Pharmaceutical Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2016-2021) & (US$ Million)
Table 102. Ono Pharmaceutical Co Ltd Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global C-C Chemokine Receptor Type 4 Market Share by Type: 2020 VS 2027
Figure 2. CCX-6239 Features
Figure 3. E-0001163 Features
Figure 4. GBV-3019 Features
Figure 5. K-777 Features
Figure 6. Others Features
Figure 7. Global C-C Chemokine Receptor Type 4 Market Share by Application: 2020 VS 2027
Figure 8. Immunology Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Mycosis Fungoides Case Studies
Figure 11. Others Case Studies
Figure 12. C-C Chemokine Receptor Type 4 Report Years Considered
Figure 13. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global C-C Chemokine Receptor Type 4 Market Share by Regions: 2020 VS 2027
Figure 16. Global C-C Chemokine Receptor Type 4 Market Share by Regions (2022-2027)
Figure 17. Global C-C Chemokine Receptor Type 4 Market Share by Players in 2020
Figure 18. Global Top C-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-C Chemokine Receptor Type 4 as of 2020
Figure 19. The Top 10 and 5 Players Market Share by C-C Chemokine Receptor Type 4 Revenue in 2020
Figure 20. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2016-2021)
Figure 21. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2022-2027)
Figure 22. North America C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America C-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 24. North America C-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 25. North America C-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 26. United States C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe C-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 30. Europe C-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 31. Europe C-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 32. Germany C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 40. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 41. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Region (2016-2027)
Figure 42. China C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America C-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 50. Latin America C-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 51. Latin America C-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 52. Mexico C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Type (2016-2027)
Figure 56. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Application (2016-2027)
Figure 57. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country (2016-2027)
Figure 58. Turkey C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE C-C Chemokine Receptor Type 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Affitech A/S Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 62. AstraZeneca Plc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 63. ChemoCentryx Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 64. Corion Biotech Srl Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 65. FLX Bio Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 66. Globavir Biosciences Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 67. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 68. Ono Pharmaceutical Co Ltd Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed